Denise Vera Scots-Knight
Chief Executive Officer & Co-Founder at Mereo BioPharma Group Plc
Denise Vera Scots-Knight
Denise Vera Scots-Knight
Chief Executive Officer & Co-Founder at Mereo BioPharma Group Plc
Overview
Career Highlights
RelSci Relationships
Number of Boards
Birthday
Age
Number of Awards
Relationships
RelSci Relationships are individuals Denise Vera Scots-Knight likely has professional access to.
A relationship does not necessarily indicate a personal connection.
In The News
GlobeNewswire
April 8, 2021
GlobeNewswire
March 31, 2021
GlobeNewswire
February 10, 2021
News Bites Canadian Markets
February 1, 2021
News Bites Canadian Markets
January 25, 2021


Paths to Denise Vera Scots-Knight
Education
BSc (Honours)
Diploma in Company Direction
Undergraduate Degree
Career History
President
2019 - Current
Chief Executive Officer & Co-Founder
2015 - Current
Managing Partner
2010 - Prior
Transactions

Public Holdings

Awards & Honors
Fulbright Scholar
Other Affiliations
Denise Vera Scots-Knight is affiliated with OncoMed Pharmaceuticals, Inc., Mereo BioPharma Group Plc, Phase4 Partners Ltd., Phase4 Partners Ltd., Nomura International Plc, Rothschild Asset Management Ltd., Rothschild & Compagnie SCS, Sagentia Ltd., Amersham Pharmacia Biotech, Inc., Fisons Plc, University of California - Berkeley
This web site is not endorsed by, directly affiliated with, maintained, authorized, or
sponsored by Denise Vera Scots-Knight. The use of any trade name or trademark is for identification and
reference purposes only and does not imply any association with the trademark holder. The
Presence of Denise Vera Scots-Knight's profile does not indicate a business or promotional relationship of
any kind between RelSci and Denise Vera Scots-Knight.